Company Filing History:
Years Active: 2003
Title: Akin H Davulcu: Innovator in HIV Research
Introduction
Akin H Davulcu is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that can inhibit HIV reverse transcriptase. His work is crucial in the ongoing fight against HIV/AIDS.
Latest Patents
Akin H Davulcu holds a patent for the asymmetric synthesis of quinazolin-2-ones, which are useful as HIV reverse transcriptase inhibitors. This invention focuses on the chiral ligand mediated addition of cyclopropylacetylide, providing a novel approach to synthesizing these important compounds. He has 1 patent to his name.
Career Highlights
Akin H Davulcu is associated with Bristol-Myers Squibb Pharma Corporation, a leading biopharmaceutical company. His work at this organization has allowed him to contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Throughout his career, Akin has collaborated with esteemed colleagues such as Rodney L Parsons and Roberta L Dorow. These partnerships have enhanced the quality and impact of his research.
Conclusion
Akin H Davulcu's innovative work in the synthesis of HIV inhibitors showcases his dedication to advancing medical science. His contributions are vital in the ongoing battle against HIV/AIDS, and his patent reflects his commitment to improving health outcomes.